Diffusion Pharmaceuticals Alpha and Beta Analysis
| DFFNDelisted Stock | USD 3.27 0.17 5.48% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Diffusion Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Diffusion Pharmaceuticals over a specified time horizon. Remember, high Diffusion Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Diffusion Pharmaceuticals' market risk premium analysis include:
Beta 0.3 | Alpha (0.53) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Diffusion |
Diffusion Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Diffusion Pharmaceuticals market risk premium is the additional return an investor will receive from holding Diffusion Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Diffusion Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Diffusion Pharmaceuticals' performance over market.| α | -0.53 | β | 0.30 |
Diffusion Pharmaceuticals Fundamentals Vs Peers
Comparing Diffusion Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Diffusion Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Diffusion Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Diffusion Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Diffusion Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Diffusion Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Diffusion Pharmaceuticals to competition |
| Fundamentals | Diffusion Pharmaceuticals | Peer Average |
| Return On Equity | -0.64 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Current Valuation | (6.02 M) | 16.62 B |
| Shares Outstanding | 2.04 M | 571.82 M |
| Shares Owned By Insiders | 0.23 % | 10.09 % |
| Shares Owned By Institutions | 10.27 % | 39.21 % |
| Number Of Shares Shorted | 2.54 K | 4.71 M |
Diffusion Pharmaceuticals Opportunities
Diffusion Pharmaceuticals Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Services PMI at 51.9 April 2023 Services ISM Report On ... - PR Newswire | 05/03/2023 |
2 | EIP Pharma to Present at JMP Securities Life Sciences Conference | 05/11/2023 |
3 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFN | 05/23/2023 |
4 | How movies impact stigma and choice Evidence from the ... - Ideas for India | 06/06/2023 |
5 | StockNews.com Begins Coverage on Diffusion Pharmaceuticals | 07/11/2023 |
About Diffusion Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Diffusion or other delisted stocks. Alpha measures the amount that position in Diffusion Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Diffusion Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Diffusion Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Diffusion Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Diffusion Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Diffusion Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Diffusion Pharmaceuticals' management manipulating its earnings.
| 13th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Build Portfolio with Diffusion Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Diffusion Stock
If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |